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ABSTRACT
Amniotic fluid Gram stain and culture have been utilized as laboratory tests ofmicrobial invasion of
the amniotic cavity. The Gram stain of amniotic fluid has a low sensitivity in the detection ofclinical
infection or microbial invasion of the amniotic cavity, and amniotic fluid culture results are not
immediately available for management decisions. Glucose concentration is used to diagnose infec-
tion in other sites such as cerebrospinal fluid.
Objective: The purpose of this study was to evaluate the usefulness of amniotic fluid glucose
concentration in detecting microbial invasion of the amniotic cavity associated with preterm labor
and preterm premature rupture ofmembranes.
Methods: Amniocentesis was performed in 60 women with preterm labor and/or preterm prema-
ture rupture of membranes. Gram stain and culture for Mycoplasma hominis, Ureaplasma urealyti-
cum, aerobic, and anaerobic bacteria were performed. Subjects were studied prospectively for the
development of positive amniotic fluid cultures and the development of clinical chorioamnionitis.
Results: The diagnosis of clinical chorioamnionitis was made in 25% (15/60) of women entered
into the study. Low amniotic fluid glucose concentration was considered < 15 mg/dl. The sensitivity,
specificity, and positive predictive value of low amniotic, fluid glucose concentration to predict
clinical chorioamnionitis were 73.3%, 88.1%, and 68.8% respectively, while positive amniotic fluid
culture, had a sensitivity of 43.8%, specificity of 79.5%, and positive predictive value of43.8%.
Conclusions: Amniotic fluid glucose concentration was more sensitive in predicting chorioam-
nionitis than either Gram stain or culture. Amniotic fluid glucose concentration was better in
predicting clinical chorioamnionitis than predicting positive amniotic fluid culture results. Gesta-
tional age-dependent normal ranges and pathologic conditions that may alter amniotic fluid glucose
concentrations should be considered when interpreting amniotic fluid glucose values to diagnose
microbial invasion ofthe amniotic cavity. (C) 1994 Wiley-Liss, Inc.
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nfection may be a significant etiologic factor in
the development of preterm labor (PTL) and
preterm premature rupture of" membranes
(PPROM). Amniocentesis is sometimes employed
to obtain amniotic fluid for analysis from patients
presenting with PTL or PPROM in order to ex-
clude infection as an underlying cause.
1-4 Amniotic
fluid culture has been utilized for the diagnosis of
microbial invasion ofthe amniotic cavity; however,
the results of bacteriologic cultures may take in
excess of 2 days. In addition, biologic properties of
amniotic fluid such as bacteriolytic/static activity
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may potentially result in negative culture results, s
The Gram stain is a rapid test that provides useful
information for clinical management. However, at
least 105 organisms/ml must be present to de-
tect microbial invasion of the amniotic cavity by
Gram stain, thus limiting the sensitivity of amni-
otic fluid Gram stain to 45%.
6
Low glucose concentration has been used as a
marker for detecting infection in cerebrospinal fluid
(CSF).
7-1 Recently the use of amniotic fluid glu-
cose concentration has been reported in the detec-
tion of microbial invasion of the amniotic cavity in
patients with PTL and PPROM.
11-4 The pur-
pose of this study was to compare the value ofGram
stain ofamniotic fluid and amniotic fluid glucose in
the identification of microbial invasion ofthe amni-
otic cavity and the development of clinical chorio-
amnionitis in patients presenting with PTL or
PPROM. The relationship between presenting
clinical diagnoses (PTL, PPROM, PTL with
PPROM) and incidence of positive diagnostic tests
was also evaluated.
MATERIALS AND METHODS
This study was conducted at Baylor College ofMed-
icine’s affiliated hospitals after approval by the Bay-
lor College ofMedicine and Harris County Hospi-
tal District institutional review boards. The period
of research was between February and December of
1990. Patients with the primary diagnosis ofPTL
or PPROM who were undergoing amniocentesis
to rule out microbial invasion ofthe amniotic cavity
were asked to enroll in the study. Patients were
enrolled if chorioamnionitis was suspected as an
underlying cause ofPTL or PPROM, but not if a
clinical diagnosis of chorioamnionitis had already
been made.
PTL was defined as regular painful uterine con-
tractions with a frequency of at least three contrac-
tions within 10 minutes or documented cervical
change. PPROM was confirmed by speculum ex-
amination with nitrazine and fern testing. The clin-
ical diagnosis ofchorioamnionitis was made accord-
ing to the criteria described by Gibbs and co-
workerss as a syndrome of fever, with either
maternal or fetal taehycardia, uterine tenderness,
foul-smelling amniotic fluid, or peripheral blood
leukocytosis.
Patients with antecedent antimicrobial therapy
within month of presentation were excluded from
the study. Patients were enrolled in the study re-
gardless of previous tocolytic therapy, which in-
cluded terbutaline or magnesium sulfate. Patients
with known glucose intolerance were excluded from
the study.
Amniocentesis was performed under local anes-
thesia and with ultrasound guidance. Samples of
amniotic fluid were submitted to the hospital labo-
ratory for clinically indicated tests such as Gram
stain, culture and sensitivity, and pulmonary matu-
rity studies.
The remainder of the amniotic fluid specimen
was used for this study. Amniotic fluid was placed
in a BBL Port-a-cul vial (Becton Dickinson and
Company, Cockeysville, MD) and in separate ster-
ile polypropylene tubes (Becton Dickinson Lab-
ware, Lincoln Park, NJ) that were immediately
refrigerated and transported for storage in a 70C
freezer until glucose assay.
Gram stain was performed with reagents (BBL
Microbiology Systems, Cockeysville, MD) under
standard conditions. Quantitation of both microor-
ganisms and white blood cells (WBCs) were as
follows: 0, none present; < -I-, to occasional/oil
immersion field (OIF); +, 1/OIF; 2 +, 2-5/OIF;
3 +, 5-10/OIF; and 4+, > 10/OIF.
Culture media were obtained from Regional Me-
dia Laboratories, Inc. (REMEL, Lenexa, KS).
Samples were placed on blood agar (Trypticase Soy
Agar (TSA) with 5% sheep blood), chocolate agar,
Thayer Martin agar (improved), and phenylethyl
alcohol (PEA) agar with 5% sheep blood at 35C in
a CO2 incubator. Amniotic fluid was plated on
MacConkey’s agar in a 35C non-CO2 incubator.
Anaerobic cultures were plated on anaerobic KV
blood agar [Centers for Disease Control (CDC)
formulation] and anaerobic PEA blood agar (CDC
formulation) and grown in an anaerobic chamber at
35C. A-7 medium was utilized for the isolation of
Mycoplasma and Ureaplasma (Scott Lab) and incu-
bated at 35C in CO2. Quantitative amniotic fluid
cultures were performed with a Il/ml loop. Am-
niotic fluid cultures were considered positive if
Mycoplasma or Ureaplasma were isolated.
Amniotic fluid glucose concentrations were de-
termined in singlicate using the glucose oxidase
method. Amniotic fluid glucose measurements were
not used in the clinical management of patients.
Subjects with positive amniotic fluid Gram stains
were placed on antibiotics and then were delivered.
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Fig. I. Relationship of amniotic fluid glucose concentrations in patients with PTL and/or PPROM to
amniotic fluid Gram stain, amniotic fluid culture, and development of clinical chorioamnionitis. Bars
represent median values. 1+-4+ see text for explanation.
Statistical analysis was performed using the
Mann-Whitney test to compare non-parametric
variables between the infected and non-infected
groups. Fisher exact analysis (two-tailed test) was
used to compare clinical outcomes between the
groups with normal and low amniotic fluid glucose
concentration. Diagnostic indices (sensitivity, spec-
ificity, positive predictive value, and negative pre-
dictive value) were used in the prediction of posi-
tive amniotic fluid cultures and development of
clinical chorioamnionitis.
RESULTS
Sixty women were enrolled in the study, 34 with
PTL, 19 with PROM, and 7 with both PTL and
PPROM. Median (range) maternal age was 25
years (15-41), and median (range) gravidity and
parity were 2 (1-8) and (0-6), respectively.
Subjects with positive amniotic fluid cultures
had significantly lower (P < 0.05, Mann-Whit-
ney) median amniotic fluid glucose concentrations
(16.0 vs. 30.0 mg/dl), est.imated gestational age at
delivery (30.6 vs. 33.4 weeks), amniocentesis-to-
delivery interval (9.8 vs. 174.0 hours), and birth-
weight (1,514 vs. 2,020 g). There was no statisti-
ca1 difference in serum WBC (12.9 vs.
11.6 103/mm3) or estimated gestational age at
presentation (30.4 vs. 32.0 weeks).
Subjects who developed clinical chorioamnioni-
tis had significantly lower median amniotic fluid
glucose concentrations (9.0 vs. 33.0 mg/dl), esti-
mated gestational age at presentation (29.7 vs. 32.0
weeks), estimated age at delivery (29.7 vs. 33.7
weeks), amniocentesis-to-delivery interval (8.5 vs.
203.0 hours), and birthweight (1,280 vs. 2,145
grams). There was no significant difference in se-
rum WBC (14.8 vs. 11.3 103/mm3) at presen-
tation.
Figure depicts the relationship of amniotic
fluid glucose concentration to amniotic fluid Gram
stain for WBCs, amniotic fluid Gram stain for
microorganisms, amniotic fluid culture, and the
development of clinical chorioamnionitis. A signif-
icant difference (P < 0.05) was seen between pa-
tients with negative Gram stain for WBCs versus
those with + to 4+ WBCs. The median amniotic
fluid glucose concentration for those patients with
positive Gram stain for organisms was 17 mg/dl,
while that of those with a negative Gram stain for
organisms was 30 mg/dl.
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TABLE I. Laboratory tests to predict positive amniotic fluid cultures
a
Sensitivity
+ Amniotic fluid culture
Specificity PPV NPV
Amniotic fluid Gram stain for organisms
Amniotic fluid Gram stain for WBCs
Amniotic fluid glucose concentration < 15 mg/dl
43.8 100 100 82.7
68.8 79.1 55.0 87.2
43.8 79.5 43.8 79.S
aPPV, positive predictive value; NPV, negative predictive value.
TABLE 2. Laboratory tests to predict clinical chorioamnionitis
Sensitivity
+ Clinical chorioamnionitis
Specificity PPV NPV
Amniotic fluid Gram stain for organisms
Amniotic fluid Gram stain for WBCs
Amniotic fluid culture
Amniotic fluid glucose concentration < 15 mg/dl
21.4 95.2 60.0 78.4
64.3 81.0 52.9 87.2
60.0 88. 64.3 86.0
73.3 88. 68.8 90.2
aPPV, positive predictive value; NPV, negative predictive value.
The sensitivity, specificity, and positive predic-
tive value (PPV) of amniotic fluid glucose to detect
positive amniotic fluid culture were 43.8, 79.6,
and 43.8%, respectively, at < 15 mg/dl; and 50.0,
79.6, and 47.1%, respectively, at < 16 mg/dl. The
sensitivity, specificity, and PPV of an amniotic
fluid glucose < 15 mg/dl to detect clinical chorio-
amnionitis were 73.3, 88.1, and 68.8%, respec-
tively. Raising the cutoff point to < 16 mg/dl
changed the sensitivity, specificity, and PPV to
76.9, 85.1, and 58.8%, respectively. A cutoffvalue
for low amniotic fluid glucose concentration was
chosen as < 15 mg/dl for comparison with other
laboratory techniques. When cultures positive only
for Mycoplasma and Ureaplasma were considered
negative, the sensitivity and specificity of low am-
niotic fluid glucose at a cutoff of 15 mg/dl to detect
positive cultures were 37.5% and 75%, respec-
tively. This was not appreciably different from
values obtained by considering the isolation ofMy-
coplasma and Ureaplasma as positive amniotic fluid
cultures.
Validity analysis of amniotic fluid glucose and
other laboratory tests for the prediction of positive
amniotic fluid cultures and clinical chorioamnioni-
tis are depicted in Tables and 2. Amniotic fluid
glucose appears to be more sensitive in detecting
clinical chorioamnionitis than Gram stain for mi-
croorganisms and Gram stain for WBCs and amni-
otic fluid culture (Table 2). Low amniotic fluid
glucose concentration appears to be a better predic-
tor of the subsequent development of clinical chori-
oamnionitis (Table 2, sensitivity 73.3%) than
the development of positive amniotic fluid culture
(Table 1, sensitivity 43.8%).
Of the 60 study subjects, 44 had normal amni-
otic fluid glucose concentration and 16 had low
amniotic fluid glucose concentration. There was a
significantly increased incidence of clinical chorio-
amnionitis (68.8 vs. 9.1%, P < 0.001, Fisher ex-
act test) and delivery within 72 hours (75.0 vs.
38.6%, P < 0.004) in the group with low amni-
otic fluid glucose concentration. The increased in-
cidence of positive amniotic fluid cultures (43.8 vs.
20.5%) in the low amniotic fluid glucose group did
not reach statistical significance.
Among the 16 patients who were found to have
positive amniotic fluid cultures, 8 cultures were
positive only for Mycoplasma spp. (Table 3). Thus,
at least one-half of patients with positive cultures
would be expected to have negative Gram stains for
organisms. There were nine false negative and no
false positive Gram stains for microorganisms. Nine
of the 16 patients with positive cultures did not
develop clinical chorioamnionitis. Of these nine
patients, eight demonstrated normal amniotic fluid
glucose concentration. There was no statistical dif-
ference between amniotic fluid glucose concentra-
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TABLE 3. Results of 16 positive amniotic fluid cultures among 60 women with PTL and/or PPROM undergoing
amniocentesis to rule out intra-amniotic infection
a
Pt At amniocentesis Amniotic fluid Gram stain
no. Diagnosis EGA (wks) Organisms WBC
AF glucose
Amniotic fluid culture mg/dl Clinical chorio.
3 PTL 29. NOS 2+ Ureaplasrna 4 No
5 PTL 32.4 NOS O+ Ureaplasrna 64 No
7 PROM 31. NOS O+ Ureaplasma 33 No
10 PROM 33.9 NOS O+ Ureaplasma 37 No
II PROM 31.7 NOS O+ Ureaplasma, N. gonorrhoeae 6 Yes
12 PTL 17.6 NOS 2+ Ureaplasrna 9 Yes
14 PROM 30.3 < I+ yeast 0+ > l0 C,. albicans 18 No
21 PTL 30.4 NOS 4+ 1.8 X 104 t. ochracea 8 Yes
23 PROM, PTL 23.4 I+ GPC, 2+ GNR 4+ > l0 G. vaginalis 3 Yes
37 PROM 30.6 NOS < + Ureaplasrna 12 Yes
38 PROM 29.0 4+ GNDC 3+ > x l0 N. gonorrhoeae 17 Yes
41 PROM 33.3 + GNR < + 7.5 X 104 H. influenzae 15 No
45 PTL, PROM 26.3 4+ GPC I+ > l0 S. agalactiae 17 No
55 PROM, PTL 29.7 NOS 4+ Ureaplasrna Yes
56 PTL 29.4 3+ yeast, 4+ GPR 4+ Ureaplasrna, Mycoplasrna 40 No
58 PTL 3 I. < + GPR > x l0 Lactobacillus spp., 27 No
< I+ yeast I+ 3 103 C. albicans
aNOS, no organisms seen; GPC, Gram positive cocci; GNR, Gram negative rods; GNDC, Gram negative diplococci; GPR, Gram positive rods; EGA,
estimated gestational age; AF, amniotic fluid. For organism and WBC counts, see text.
tions in amniotic fluid cultures positive for Myco-
plasma spp. versus bacterial species. No anaerobic
organisms were isolated from culture.
Among the 16 patients with positive amniotic
fluid cultures, 7 had PPROM, 6 had PTL, and 3
had PPROM with PTL. There was no significant
difference in amniotic fluid glucose concentration
between patients with PPROM and PTL (19.7 vs.
25.3 mg/dl; P 0.58).
Amniotic fluid WBC count was lower in associ-
ation with PPROM than with PTL; however, this
did not reach statistical significance (0.57 + vs.
2.08 + ;P 0.077). The relationships between
primary clinical diagnoses (PTL, PPROM, or
PTL with PPROM) and clinical tests or outcomes
are shown in Figure 2.
Among the 16 patients with low amniotic fluid
glucose (<15 mg/dl), 6 had negative cultures and
did not develop chorioamnionitis. One patient with
Rh alloimmunization prematurely delivered 18
hours following amniocentesis. One patient deliv-
ered in 6 hours with abruptio placentae, which was
believed to be the underlying cause of PTL. An-
other patient with PTL delivered in 91 hours with
fetal distress and suspected pregnancy-induced hy-
pertension. A patient with PPROM and oligohy-
dramnios delivered after 232 hours with fetal dis-
tress; the neonate was found to have congenital
syphilis. Two patients with low amniotic fluid glu-
cose and negative cultures had prolonged amnio-
centesis-to-delivery times of 36 and 44 days.
DISCUSSION
The effects of leukocytes and bacteria on the glu-
cose concentration of CSF in bacterial meningitis
have been well established.
7 Both activated leuko-
cytes and bacteria are required to lower CSF glu-
cose concentration.
8-10 Altered glucose transport
across inflamed membranes has also been a pro-
posed mechanism for hypoglycorrhachia in bacte-
rial meningitis.
16 This understanding makes it
plausible that the presence of bacteria andactivated
leukocytes in amniotic fluid may result in decreased
concentrations of glucose.
Weiss and colleagues
17 studied 2,295 samples of
amniotic fluid obtained between the 14th and 42nd
weeks of pregnancy. Mean amniotic fluid glucose
concentration in normal pregnancy rose between
the 14th and 17th weeks of pregnancy and then
declined steadily toward term. They reported the
tenth percentile of amniotic fluid glucose concen-
tration for normal pregnancies at 28/29, 30/31,
32/33, 34/35, 36/37, and 38/39 weeks of gestation
to be 20, 18, 17, 16, 14, and 12 mg/dl, respec-
tively. Amniotic fluid glucose concentration may
be elevated in diabetic pregnancies and reduced in
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pregnancies complicated by growth retardation or
fetal malformation.
17-19
All papers published to date regarding amniotic
fluid glucose concentration in detecting microbial
invasion of the amniotic cavity have reported dif-
ferent thresholds oflow amniotic fluid glucose.
11-14
Romero and colleagues
11 studied 168 women with
PTL and intact membranes. They found that a
cutoff of <14 mg/dl resulted in a reasonable com-
promise between the true positive and false positive
rate. With this threshold, the sensitivity, specific-
ity, and PPV were 86.9%, 91.7%, and 62.5%,
respectively. Kirshon and associates
lz studied 39
patients with PTL and/or PPROM. All nine pa-
tients with microbial invasion of the amniotic cav-
ity were noted to have amniotic fluid glucose con-
centrations of < 10 mg/dl, and none with > 10
mg/dl developed chorioamnionitis. Kiltz and co-
workers
13 evaluated the amniotic fluid glucose con-
centrations of 84 patients who were either in PTL,
near term but not in labor, or at term in labor.
They found that an amniotic fluid glucose concen-
tration < 5 mg/dl had a PPV of 90% for positive
culture and at > 20 mg/dl had a NPV of 98%. The
PPV at < 15 mg/dl was 46%, and the NPV
at > 15 mg/dl was 97%. The PPV for amniotic
fluid glucose concentration in our study was 43.8%
at < 15 mg/dl and 47.1% at < 16 mg/dl, similar
to the findings of Kiltz and co-workers.
In the clinical setting of PTL or PPROM, the
ramifications of a false positive test include induc-
tion of labor and premature delivery, which are
highly undesirable. Likewise, the results of clinical
action based upon a false negative test may include
unwarranted tocolysis, delayed delivery and with-
holding of antibiotic therapy, which may lead to
adverse maternal and neonatal outcomes. We chose
to use 15 mg/dl as a cutoff for normal amniotic
fluid glucose concentration based upon the ability
to predict positive cultures and the development of
clinical chorioamnionitis. Analysis ofour data dem-
onstrates that this threshold for amniotic fluid glu-
cose concentration is comparable or superior to the
other laboratory tests evaluated for detection of clin-
ical chorioamnionitis, but not for positive cultures.
It should be recognized that immediate delivery for
positive amniotic fluid Gram stain or culture may
have a significant effect in reducing the number of
subjects who would later develop clinical chorioam-
nionitis.
It appears that a cutoff for amniotic fluid glucose
concentration at 15 mg/dl would be appropriate for
general clinical use at this time. The use of a lower
cutoff point would reduce the false positive rate at
the expense of sensitivity, especially at earlier gesta-
tional ages. Studies examining the factor of gesta-
tional age have not yet been conducted. Gestational
age may play an important role in interpretation of
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these data, since an amniotic fluid glucose concen-
tration of 14 mg/dl may actually be normal at 3 5
weeks but considered low at 3 2 weeks of gestation.
This is demonstrated by our data in Table 3: four
patients (numbers 14, 38, 41, and 45)were found
to have normal (> 15 mg/dl) amniotic fluid glu-
cose concentrations in the presence of both positive
Gram stain for microorganisms and positive amni-
otic fluid cultures. If gestational age were taken
into consideration, these four patients would have
been considered to have low amniotic fluid glucose.
Further studies examining the effects of gestational
age appear warranted. Due to limitations in sensi-
tivity and specificity, we recommend that amniotic
fluid glucose concentration should not be used alone
in making clinical decisions, but should be factored
in with clinical signs, symptoms, and other labora-
tory tests.
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